Bronwyn M Kivell

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Molecules (Basel, Switzerland)

Brain sciences

Clinical & translational immunology

Victoria University of Wellington

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Victoria University of Wellington

New Zealand

Associate Professor :: School of Biological Sciences

Publications

Ross van de Wetering, Amy Ewald, Susan Welsh, Lindsay Kornberger, Samuel E Williamson, Bryan D McElroy, Eduardo R Butelman, Thomas E Prisinzano, Bronwyn M Kivell
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules (Basel, Switzerland) 28 (12) (2023)
Ross van de Wetering, Amy Ewald, Susan Welsh, Lindsay Kornberger, Samuel E Williamson, Bryan D McElroy, Eduardo R Butelman, Thomas E Prisinzano, Bronwyn M Kivell
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules (Basel, Switzerland) 28 (12) (2023)
Ross van de Wetering, Amy Ewald, Susan Welsh, Lindsay Kornberger, Samuel E Williamson, Bryan D McElroy, Eduardo R Butelman, Thomas E Prisinzano, Bronwyn M Kivell
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules (Basel, Switzerland) 28 (12) (2023)
Ross van de Wetering, Amy Ewald, Susan Welsh, Lindsay Kornberger, Samuel E Williamson, Bryan D McElroy, Eduardo R Butelman, Thomas E Prisinzano, Bronwyn M Kivell
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules (Basel, Switzerland) 28 (12) (2023)
Kelly F Paton, Sheein Hong, Andrew Biggerstaff, Bronwyn M Kivell
Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in Mice. Brain sciences 12 (12) (2022)
Kelly F Paton, Sheein Hong, Andrew Biggerstaff, Bronwyn M Kivell
Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in Mice. Brain sciences 12 (12) (2022)
Lisa Denny, Afnan Al Abadey, Katharina Robichon, Nikki Templeton, Thomas E Prisinzano, Bronwyn M Kivell, Anne Camille La Flamme
Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease. Clinical & translational immunology 10 (1) (2021)
Bronwyn M Kivell, Kelly F Paton, Nitin Kumar, Aashish S Morani, Aimee Culverhouse, Amy Shepherd, Susan A Welsh, Andrew Biggerstaff, Rachel S Crowley, Thomas E Prisinzano
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents. Molecules (Basel, Switzerland) 23 (10) (2018)

Bronwyn M Kivell.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bronwyn M Kivell